Skip to main content
CO

Convelo Therapeutics

Cleveland, United States
Last funding
$10.8M
Venture - Series UnknownDec 2022

Convelo Therapeutics specializes in developing medicines to regenerate myelin around nerve cells and restore function

Backed byZanite Ventures

About Convelo Therapeutics

How much funding has Convelo Therapeutics raised?

Convelo Therapeutics has raised $10.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2022.

Who are Convelo Therapeutics's investors?

Convelo Therapeutics's investors include Zanite Ventures.

Where is Convelo Therapeutics headquartered?

Convelo Therapeutics is headquartered in Cleveland, United States.

What does Convelo Therapeutics do?

Convelo Therapeutics specializes in developing medicines to regenerate myelin around nerve cells and restore function

What stage is Convelo Therapeutics at?

Convelo Therapeutics is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Convelo Therapeutics — Funding & Investors." VCBacked, December 8, 2022, https://www.vcbacked.co/company/convelo-therapeutics. Accessed November 14, 2026.
APA
VCBacked. (2022). Convelo Therapeutics — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/convelo-therapeutics
Wikipedia (cite web)
{{cite web |title=Convelo Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/convelo-therapeutics |website=VCBacked |access-date=November 14, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Convelo Therapeutics? Request a listing update

Founder contacts
m***@convelotx.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →